Concord Biotech public shareholder sells shares worth Rs 483 crore
The shares were disposed of at an average price of Rs 1,361.26 apiece, taking the deal value to Rs 483 crore.
A public shareholder of pharmaceutical company Concord Biotech on Tuesday sold a 3.4 per cent stake in the company for Rs 483 crore through an open market transaction.
According to the bulk deal data available with the National Stock Exchange (NSE), 1575773 Ontario Inc offloaded 35,48,211 shares, amounting to a 3.4 per cent stake in Concord Biotech.
The shares were disposed of at an average price of Rs 1,361.26 apiece, taking the deal value to Rs 483 crore.
After the stake sale, shareholding of 1575773 Ontario Inc in Concord Biotech has declined to 1.99 per cent from 5.39 per cent.
Meanwhile, Norges Bank, on account of the Government Pension Fund Global acquired 6 lakh shares or 0.57 per cent stake in Concord Biotech.
Details of the other buyers could not be ascertained.
On Tuesday, shares of Concord Biotech fell 2.41 per cent to close at Rs 1,406 apiece on the NSE.
Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.
RECOMMENDED STORIES
SIP+SWP: Rs 20,000 monthly SIP for 16 years to get Rs 99,000 monthly income for 42 years; how is it possible?
GMR Airports Infra and 4 more: Axis Direct recommends buying 5 stocks for 5-15 days | Check targets, stop losses
RVNL, Bajaj Finserv and 5 more: Brokerage recommends buying these 7 stocks for up to 3 months | Check target, stop loss
SBI Senior Citizen FD Rates 2024: What you can get if you invest Rs 3 lakh, Rs 5 lakh, Rs 7 lakh, and Rs 9 lakh in 1-, 3-, and 5-year FDs
NPS vs UPS vs OPS: What will be your monthly pension if you contribute Rs 10,000 monthly for 35 years? Get expert calculations
07:39 AM IST